Loading...

Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma

Immune checkpoint therapy has resulted in minimal clinical response in many pediatric cancers. We sought to understand the influence of immune checkpoint inhibition using anti-PD-1 and anti-CTLA-4 antibodies individually, in combination, and after chemotherapy on immune responses in minimal and esta...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncoimmunology
Main Authors: Shirinbak, Soheila, Chan, Randall Y., Shahani, Shilpa, Muthugounder, Sakunthala, Kennedy, Rebekah, Hung, Long T., Fernandez, G. Esteban, Hadjidaniel, Michael D., Moghimi, Babak, Sheard, Michael A., Epstein, Alan L., Fabbri, Muller, Shimada, Hiroyuki, Asgharzadeh, Shahab
Format: Artigo
Sprog:Inglês
Udgivet: Taylor & Francis 2021
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7801125/
https://ncbi.nlm.nih.gov/pubmed/33489468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1838140
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!